JATOLPIA Trademark

Trademark Overview

On Tuesday, June 20, 2017, a trademark application was filed for JATOLPIA with the United States Patent and Trademark Office. The USPTO has given the JATOLPIA trademark a serial number of 87498131. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 7, 2025. This trademark is owned by Glaxo Group Limited. The JATOLPIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
jatolpia

General Information

Serial Number87498131
Word MarkJATOLPIA
Filing DateTuesday, June 20, 2017
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 7, 2025
Registration Number5543767
Registration DateTuesday, August 21, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 24, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 7, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Tuesday, August 22, 2017SUSPENSION LETTER WRITTEN
Friday, June 23, 2017NEW APPLICATION ENTERED
Tuesday, June 27, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 18, 2017ASSIGNED TO EXAMINER
Tuesday, August 22, 2017LETTER OF SUSPENSION E-MAILED
Tuesday, August 22, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, August 31, 2017TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, September 11, 2017ASSIGNED TO LIE
Tuesday, September 12, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 12, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 15, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, September 18, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, October 4, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 24, 2017PUBLISHED FOR OPPOSITION
Tuesday, October 24, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 19, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 12, 2018SOU TEAS EXTENSION RECEIVED
Tuesday, June 12, 2018SOU EXTENSION 1 FILED
Tuesday, June 12, 2018SOU EXTENSION 1 GRANTED
Wednesday, June 13, 2018TEAS DELETE 1(B) BASIS RECEIVED
Wednesday, June 13, 2018NOTICE OF ALLOWANCE CANCELLED
Thursday, June 14, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 19, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 19, 20181(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, August 21, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, November 8, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 8, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, August 11, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, August 11, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, August 11, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 11, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 11, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 21, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, March 7, 2025CANCELLED SEC. 8 (6-YR)

Related Keywords

jatolpia pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological